Rani Therapeutics Holdings Inc - Ordinary Shares Class A Forecast, price target & analysts
Rani Therapeutics Holdings Inc - Ordinary Shares Class A Target price 2026 - Analyst rating & recommendation
Rani Therapeutics Holdings Inc - Ordinary Shares Class A Classifications & Recommendation
Rani Therapeutics Holdings Inc - Ordinary Shares Class A Price Target
| Target Price | $6.12 |
| Price | $0.86 |
| Potential |
609.98%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Rani Therapeutics Holdings Inc - Ordinary Shares Class A 2027 .
The average Rani Therapeutics Holdings Inc - Ordinary Shares Class A target price is $6.12.
This is
609.98%
register free of charge
$11.55
1,239.91%
register free of charge
$5.05
485.85%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Rani Therapeutics Holdings Inc - Ordinary Shares Class A to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Rani Therapeutics Holdings Inc - Ordinary Shares Class A stock has an average upside potential 2027 of
609.98%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 1.63 | 5.08 |
| 58.25% | 211.47% | |
| EBITDA Margin | -2,295.09% | -1,143.42% |
| 51.33% | 50.18% | |
| Net Margin | -1,820.25% | -520.94% |
| 37.55% | 71.38% |
6 Analysts have issued a sales forecast Rani Therapeutics Holdings Inc - Ordinary Shares Class A 2026 . The average Rani Therapeutics Holdings Inc - Ordinary Shares Class A sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Rani Therapeutics Holdings Inc - Ordinary Shares Class A EBITDA forecast 2026. The average Rani Therapeutics Holdings Inc - Ordinary Shares Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Rani Therapeutics Holdings Inc - Ordinary Shares Class A Analysts have issued a net profit forecast 2026. The average Rani Therapeutics Holdings Inc - Ordinary Shares Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.45 | -0.19 |
| 57.14% | 57.78% | |
| P/E | negative | |
| EV/Sales | 13.15 |
6 Analysts have issued a Rani Therapeutics Holdings Inc - Ordinary Shares Class A forecast for earnings per share. The average Rani Therapeutics Holdings Inc - Ordinary Shares Class A EPS is
This results in the following potential growth metrics and future valuations:
Rani Therapeutics Holdings Inc - Ordinary Shares Class A...
Current Rani Therapeutics Holdings Inc - Ordinary Shares Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Aug 18 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 20 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Apr 01 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 27 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 09 2026 |
| Maxim Group |
Locked
➜
Locked
|
Locked | Oct 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Aug 18 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 20 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Apr 01 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 27 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 09 2026 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
Oct 20 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
